Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH
极端 pH 条件下连续流动、不含两性电解质的基于 pI 的分选肽/蛋白质
基本信息
- 批准号:7788037
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdvanced DevelopmentAmpholyte MixturesAmpholytesBinding ProteinsBiologicalBiological AssayBiological MarkersBiologyBiomedical EngineeringBiosensorBrain DiseasesBuffersCell physiologyCellsChargeClinicalComplexCouplingDNA-Binding ProteinsDataDetectionDevicesDiseaseDisease MarkerElectrophoresisElementsFractionationGelGenesGoalsHistonesHourImmunoassayIon-Exchange Chromatography ProcedureIsoelectric FocusingIsoelectric PointLifeMass Spectrum AnalysisMembraneMicrofluidic MicrochipsMicrofluidicsMissionMyelinNational Institute of Biomedical Imaging and BioengineeringOrganismPeptidesPower SourcesPreparationProcessProteinsProteomeProteomicsProtocols documentationReagentRibosomal ProteinsSamplingSchemeSignaling MoleculeSolutionsSorting - Cell MovementSourceStomach CarcinomaSystemTechniquesTissuesTitrationsTwo-Dimensional Gel ElectrophoresisWorkanalytical toolbasecell typeelectric fieldhuman diseaseimprovedinter-alpha-inhibitorinterestnovelnumb proteinoperationpH gradientpromoterprotein complexpublic health relevancetool
项目摘要
DESCRIPTION (provided by applicant): In view of the complexity of the expressed proteome in a given cell type, tissue, or organism, proper sample preparation is absolutely critical for subsequent analysis by 2D gel electrophoresis or mass spectrometry. The isoelectric focusing (IEF), with its high resolving power, is one of the most common techniques used for sample preparation. IEF allows a fractionation of a complex sample based on the isoelectric points (pI) of the proteins. The pH gradient necessary for pI-based fractionation is generated either by carrier ampholytes or by immobilized IPG gels. In this project, we propose a novel continuous-flow, ampholyte-free pI-based sorting technique based on free-flow zone electrophoresis that can fractionate complex proteins/peptides only using a common buffer solution. Instead of generating a broad pH gradient and performing a parallel fractionation in a single step, as is the case with the current ampholyte- or gel-based IEF techniques, the sample mixture is sequentially titrated down inside the microfluidic channel and fractionated into a specific pI range after each sorting step. The sequential sorting scheme works in continuous-processing mode and can achieve a high throughput with a flow rate of 1-5 5L/min that allows processing a sample volume up to 100 5L within half an hour. The required electric field is supplied from an external power source through a robust self-assembled bead membrane. For the sake of simplicity in the device fabrication and operation, we propose to couple just two sorting steps in a single chip and aim at a very narrow pI range isolation/extraction of molecules, the range as narrow as d 0.5 pH units, from complex samples in pH 3-10 range as well as beyond pH range. Since the pI range is freely adjustable by the titration in a micromixer, we can achieve a narrow pI range isolation in the acidic and, more importantly, in the basic range where the conventional IPG offers only broad range strips (e pH 3.0 units). This continuous-flow sorting technique will offer a new possibility to extend the current pH range to extremely acidic (pH < 3) or basic conditions (pH > 10), a terra incognita due to the limited pH capability of the ampholyte- and gel-based IEF techniques. A successful implementation of this project will result in a simple and downstream- compatible microfluidic sorting device that will enable an automatic, ampholyte- and gel-free, pI-based sample fractionation of proteins and peptides into a very narrow pI range (d 0.5 pH units), even at extreme pH conditions, in a high-throughput mode to accommodate the needs of targeted proteomics. Combined with RP- LC, it will offer a powerful multidimensional separation for MS analysis. It will open up a new, exciting opportunity to detect proteins and peptides at extreme pH values. Some of them might be related to human diseases such as gastric carcinoma or brain diseases. Thus, this new tool can improve the detection of diseases and help to find better treatment which is within the scope of the mission of NIBIB.
PUBLIC HEALTH RELEVANCE: The goal of this project is to develop a microfluidic pI-based sorting device which allows a continuous-flow and high-throughput fractionation of complex protein/peptide mixtures. This device will enable the fast detection and identification of proteins that are related to certain human diseases.
描述(由申请人提供):鉴于给定细胞类型、组织或生物体中表达的蛋白质组的复杂性,适当的样品制备对于随后的2D凝胶电泳或质谱分析至关重要。等电聚焦(IEF)以其高分辨能力,是样品制备中最常用的技术之一。IEF允许基于蛋白质的等电点(pI)对复杂样品进行分馏。pi基分馏所需的pH梯度是由载体两性水解物或固定化IPG凝胶产生的。在本项目中,我们提出了一种基于自由流动区带电泳的新型连续流、无两性聚合物的pi分选技术,该技术仅使用通用缓冲溶液就可以分离复杂的蛋白质/肽。不同于当前基于两性电解质或凝胶的IEF技术在单一步骤中产生广泛的pH梯度并进行平行分选,样品混合物在微流体通道内依次滴定,并在每个分选步骤后分选到特定的pI范围。顺序分选方案在连续处理模式下工作,可实现高吞吐量,流量为1-5 5L/min,可在半小时内处理高达100 5L的样品量。所需的电场由外部电源通过坚固的自组装头膜提供。为了简化设备制造和操作,我们建议在单个芯片中耦合两个分选步骤,并针对非常窄的pI范围内分离/提取分子,范围窄至d 0.5 pH单位,从pH 3-10范围以及超出pH范围的复杂样品中。由于pI范围可以通过微混合器中的滴定自由调节,因此我们可以在酸性中实现窄pI范围隔离,更重要的是,在常规IPG仅提供宽范围条带(即pH 3.0单位)的基本范围内。这种连续流分选技术将提供一种新的可能性,将当前的pH范围扩展到极酸性(pH < 3)或碱性条件(pH bbb10),这是由于两性电解质和凝胶基IEF技术的pH能力有限而未知的领域。该项目的成功实施将产生一种简单且下游兼容的微流控分选装置,即使在极端pH条件下,也可以在高通量模式下,将蛋白质和肽的自动、无两性电解质和无凝胶、基于pI的样品分离到非常窄的pI范围(d 0.5 pH单位),以适应靶向蛋白质组学的需求。与RP- LC相结合,将为质谱分析提供强大的多维分离。它将为在极端pH值下检测蛋白质和肽开辟一个新的、令人兴奋的机会。其中一些可能与人类疾病有关,如胃癌或脑部疾病。因此,这种新工具可以改进疾病的检测,并有助于找到更好的治疗方法,这是NIBIB的使命范围。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONGYOON HAN其他文献
JONGYOON HAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONGYOON HAN', 18)}}的其他基金
Continuous Production of Viral Vectors using membraneless Perfusion Culture of Host Cells
利用宿主细胞无膜灌注培养连续生产病毒载体
- 批准号:
10414312 - 财政年份:2021
- 资助金额:
$ 23.03万 - 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
- 批准号:
10201300 - 财政年份:2020
- 资助金额:
$ 23.03万 - 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
- 批准号:
10474343 - 财政年份:2020
- 资助金额:
$ 23.03万 - 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
- 批准号:
10263273 - 财政年份:2020
- 资助金额:
$ 23.03万 - 项目类别:
Novel Process Analytic Technology for Continuous Bioprocessses
用于连续生物过程的新型过程分析技术
- 批准号:
9929893 - 财政年份:2019
- 资助金额:
$ 23.03万 - 项目类别:
Novel Process Analytic Technology for Continuous Bioprocessses
用于连续生物过程的新型过程分析技术
- 批准号:
10238815 - 财政年份:2019
- 资助金额:
$ 23.03万 - 项目类别:
Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH
极端 pH 条件下连续流动、不含两性电解质的基于 pI 的分选肽/蛋白质
- 批准号:
8010211 - 财政年份:2010
- 资助金额:
$ 23.03万 - 项目类别:
Nanofluidic Tools for Proteomic Sample Preparation
用于蛋白质组样品制备的纳米流体工具
- 批准号:
7237946 - 财政年份:2005
- 资助金额:
$ 23.03万 - 项目类别:
Nanofluidic Tools for Proteomic Sample Preparation
用于蛋白质组样品制备的纳米流体工具
- 批准号:
7121548 - 财政年份:2005
- 资助金额:
$ 23.03万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:














{{item.name}}会员




